PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Nov-2019 Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults Mallinckrodt
11-Nov-2019 Original-Research: Formycon AG (von First Berlin Equity Research GmbH) Formycon AG
11-Nov-2019 DiaMonTech strengthens its international distribution network - Agreement signed for the distribution of at least 40,000 'D-Pocket' devices in Latin America DiaMonTech AG
11-Nov-2019 Secarna Pharmaceuticals successfully completes financing round Secarna Pharmaceuticals GmbH & Co. KG
11-Nov-2019 evitria Opens its New Head Office in Scandinavia B3C newswire
11-Nov-2019 Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business Expedeon AG
11-Nov-2019 Expedeon AG: Expedeon AG signs EUR 120 million deal with Abcam for the sale of its immunology and proteomics business Expedeon AG
11-Nov-2019 Presentation of ONCOS-102 Melanoma Data at SITC Annual Meeting Targovax
11-Nov-2019 Stone Capital Partners Biosyngen to Setup US$50 Million Biopharmaceutical Investment Fund in Singapore Biosyngen
10-Nov-2019 Bryn Pharma Research on Epinephrine Nasal Spray Presented at The American College of Allergy, Asthma and Immunology Annual Meeting Bryn Pharma, LLC
10-Nov-2019 Lupus Research Alliance Response to Positive Trial Testing Obinutuzumab (Gazyva®) for Lupus Nephritis Lupus Research Alliance
08-Nov-2019 Akeso, Inc. Completes Series-D Private Financing for US$150 Million Akeso, Inc.
08-Nov-2019 Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Mallinckrodt plc
08-Nov-2019 Pooled Analyses of Bempedoic Acid Phase 3 LDL-C Lowering Clinical Trial Programme to be Presented at the American Heart Association 2019 Scientific Sessions Daiichi Sankyo
08-Nov-2019 Mallinckrodt to Present at Jefferies London Healthcare Conference Mallinckrodt plc
08-Nov-2019 UKI2S wins Best Sector Support Organisation at the OBN Awards UKI2S
08-Nov-2019 OBN Awards 2019 – Winners Recognised at Industry Leading Event OBN
08-Nov-2019 RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in Revenues in the Third Quarter and in the First Nine Months RHÖN-KLINIKUM AG
08-Nov-2019 Abcam and BrickBio Announce a Partnership to Incorporate Conjugation-Ready Sites into Recombinant Antibodies Across Abcam’s Portfolio B3C newswire
08-Nov-2019 Omega-3 Fatty-acid Enriched Parenteral Nutrition Improves Patient Outcomes Fresenius Kabi Deutschland GmbH